scanance.
Sign inGet Premium
BU

First Busey Corporation

BUSEFinancial ServicesNASDAQ

Banks - Regional

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$719.6M
+55.9% YoY
Net Income
$135.3M
+19.0% YoY

Scan Results

Daily timeframe
DateIndicatorDetails
Loading...
About First Busey Corporation

First Busey Corporation operates as the bank holding company for Busey Bank that engages in the provision of retail and commercial banking products and services to individual, corporate,. At a $2.31B market cap, First Busey Corporation ranks as a mid-cap company within financial services. The company operates through three segments: Banking, Wealth Management, and FirsTech.

Key stats
Market Cap$2.31B
P/E (TTM)11.26
Fwd P/E10.10
EPS$2.43
Beta0.70
52W Change+24.6%
Dividend Yield3.80%
ROE9.4%
Analysis

The company holds $328.8M in cash, though total debt stands at $702.4M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Return on equity stands at 9.4%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 1.1% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $450.1M (2022) to $719.6M (2025), reflecting a 60% increase over the period.

As with any equity investment, BUSE carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence First Busey Corporation's trajectory.

Links
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms